Themis Medicare Limited (THEMISMED)
Investors Presentation for the quarter ended 30.06.2026
Investor Presentation - Q1 FY27
- Consolidated revenue at ₹86.96 Cr, down 10.9% y-y; PAT ₹24.6 Cr vs loss of ₹14.2 Cr in Q1 FY26
- PBT improved to ₹38.6 Cr from loss of ₹14.1 Cr; PAT margin 28.3%
- Critical care business growth driven by brand promotion; API and institution business show recovery
- R&D investment at 8% of revenue for product pipeline
- Focus on cash flow, working capital optimization, and cost efficiencies
- Management optimistic on improving momentum with operational efficiencies and cost optimization
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 THEMISMED — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add THEMISMED to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Themis Medicare Limited
Important.
The summary above is generated automatically from Themis Medicare Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.